Cargando…

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization

Recent in vivo and in vitro studies have demonstrated a wide spectrum of biologic activities of cytokines in the pathogenesis and progression of malignancy. Tumour necrosis factor alpha (TNF-α) and transforming growth factor beta (TGF-β) have emerged as two of the many host-derived mediators that se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boldrini, L, Calcinai, A, Samaritani, E, Pistolesi, F, Mussi, A, Lucchi, M, Angeletti, C A, Basolo, F, Fontanini, G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374649/ https://www.ncbi.nlm.nih.gov/pubmed/10945495 http://dx.doi.org/10.1054/bjoc.2000.1345

Ejemplares similares

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
por: Fontanini, G., et al.
Publicado: (1997)

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.
por: Fontanini, G., et al.
Publicado: (1995)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
por: Basolo, F., et al.
Publicado: (1997)

Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2017)

bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
por: Pollina, L., et al.
Publicado: (1996)

Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours
por: CAPODANNO, ALESSANDRA, et al.
Publicado: (2012)

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
por: Alì, G, et al.
Publicado: (2009)

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients
por: Boldrini, Laura, et al.
Publicado: (2018)

Expression of miRNA-25 in young and old lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2021)

Tumour necrosis factor signalling in health and disease
por: Holbrook, Jonathan, et al.
Publicado: (2019)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Fr-MLV infection induces erythroleukaemia instead of lymphoid leukaemia in mice given pituitary grafts.
por: Fontanini, G., et al.
Publicado: (1990)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Differences in tumour necrosis factor productive ability among rodents.
por: Haranaka, K., et al.
Publicado: (1984)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
por: Cecilio, C. A., et al.
Publicado: (1997)

Tumour Necrosis Factor-α Production and Immune Cell Activation in Tuberculous Meningitis
por: Mastroianni, C. M., et al.
Publicado: (1994)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
por: BOLDRINI, LAURA, et al.
Publicado: (2015)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis
por: Antunes, Ricardo F., et al.
Publicado: (2012)

The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation.
por: Guo, R. F., et al.
Publicado: (1998)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis
por: Gorouhi, F, et al.
Publicado: (2008)

Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates
por: Eberhardson, Michael, et al.
Publicado: (2022)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ouo6nhd2007rumn9n6ejjqh17b